Lineweaver Wealth Advisors LLC Has $3.34 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Lineweaver Wealth Advisors LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,730 shares of the healthcare conglomerate’s stock after acquiring an additional 402 shares during the period. UnitedHealth Group comprises 0.8% of Lineweaver Wealth Advisors LLC’s holdings, making the stock its 28th biggest holding. Lineweaver Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $3,337,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Tealwood Asset Management Inc. lifted its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after acquiring an additional 19 shares during the period. Atlas Private Wealth Advisors lifted its holdings in UnitedHealth Group by 1.1% in the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after acquiring an additional 19 shares during the period. Prentice Wealth Management LLC increased its position in shares of UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after buying an additional 19 shares in the last quarter. Baker Avenue Asset Management LP increased its position in shares of UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after buying an additional 20 shares in the last quarter. Finally, Granite Harbor Advisors Inc. increased its position in shares of UnitedHealth Group by 2.9% in the third quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock valued at $362,000 after buying an additional 20 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Royal Bank of Canada dropped their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Trading Down 0.4 %

UNH traded down $1.88 during mid-day trading on Friday, hitting $488.01. 3,498,996 shares of the stock were exchanged, compared to its average volume of 4,448,744. The firm’s fifty day moving average is $498.46 and its two-hundred day moving average is $500.70. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $449.16 billion, a PE ratio of 29.83, a PEG ratio of 1.44 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the business earned $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.72%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.